6. The daily critical compound of the successor fund recipient (successor Fund).

摘要

New Heterocyclic compounds as inducers of dimerization of the Receptor of the Fibroblast Growth Factors (FGFR) According to formula I, their Preparation Process and their Therapeutic applications.